NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market Tuesday that its fourth-quarter revenues increased 21 percent year over year, as the firm easily beat the consensus Wall Street estimates on the top and bottom line.

The South San Francisco, Calif.-based microfluidic systems developer had total revenues of $15.7 million for the three months ended Dec. 31, compared to $13 million for the fourth quarter of 2011. Analysts, on average, had expected revenues of $14.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.